Locally advanced mismatch repair‐deficient gastroesophageal junction cancer: Diagnosis, treatment modifications, and monitoring

Laparoscopic versus open approach for Siewert-type II/III adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis

(2023) Ming Wu et al.   DIGESTIVE SURGERY

INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC).

(2023) Filippo Pietrantonio et al.   JOURNAL OF CLINICAL ONCOLOGY

Advances in MRI-Guided Radiation Therapy

(2023) Michael D. Chuong et al.   Surgical Oncology Clinics of North America

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

(2022) Jaffer A. Ajani et al.   Journal of the National Comprehensive Cancer Network

Safety, efficacy, and cost-effectiveness of minimally invasive esophagectomies versus open esophagectomies: an umbrella review

(2022) Sinead E Ramjit et al.   DISEASES OF THE ESOPHAGUS

Comparison of Efficacy Between Transabdominal and Transthoracic Surgical Approaches for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis

(2022) Zonglin Li et al.   Frontiers in Oncology

Surgical and pathological outcome, and pathological regression, in patients receiving perioperative atezolizumab in combination with FLOT chemotherapy versus FLOT alone for resectable esophagogastric adenocarcinoma: Interim results from DANTE, a randomized, multicenter, phase IIb trial of the FLOT-AIO German Gastric Cancer Group and Swiss SAKK.

(2022) Salah-Eddin Al-Batran et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

(2022) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Serial Circulating Tumor DNA in Monitoring the Effect of Neoadjuvant and Adjuvant Immunotherapy in Patients With Colon Cancer: Case Series and Review of the Literature

(2022) Qiyuan Qin et al.   JOURNAL OF IMMUNOTHERAPY

Ongoing Controversies in Esophageal Cancer II

(2022) Nicolas Devaud et al.   Thoracic Surgery Clinics

Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma

(2021) Casey J. Allen et al.   ANNALS OF SURGERY

Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial

(2021) Karyn A. Goodman et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative pembrolizumab for MSI high, EBV positive or PD-L1 positive locally advanced gastric cancer followed by surgery and adjuvant chemoradiation with pembrolizumab: Interim results of a phase 2 multi-center trial (NCT03257163).

(2021) Timothy Kennedy et al.   JOURNAL OF CLINICAL ONCOLOGY

Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).

(2021) John V. Reynolds et al.   JOURNAL OF CLINICAL ONCOLOGY

Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer Center

(2021) Alexander Quaas et al.   Frontiers in Oncology

Learning curves in minimally invasive esophagectomy: A systematic review and evaluation of benchmarking parameters

(2021) Pooja Prasad et al.   SURGERY

Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center

(2020) David T. Pointer et al.   ANNALS OF SURGERY

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

(2019) Jaffer A. Ajani et al.   Journal of the National Comprehensive Cancer Network

Mismatch Repair System Deficiency Is Associated With Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

(2019) Nicolas Meillan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer

(2018) Yoon Young Choi et al.   ANNALS OF SURGERY

Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer

(2018) Pieter C. van der Sluis et al.   ANNALS OF SURGERY

Integrated genomic characterization of oesophageal carcinoma

(2017)   NATURE

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

(2017) Dung T. Le et al.   SCIENCE

Mismatch Repair Deficiency, Microsatellite Instability, and Survival

(2017) Elizabeth C. Smyth et al.   JAMA Oncology

Comprehensive molecular characterization of gastric adenocarcinoma

(2014) Adam J. Bass et al.   NATURE

Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy

(2012) Changzheng Du et al.   HISTOPATHOLOGY

The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors

(2012) Cathrin Huth et al.   MODERN PATHOLOGY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quality Assessment and Correlation of Microsatellite Instability and Immunohistochemical Markers among Population- and Clinic-Based Colorectal Tumors

(2011) Mine S. Cicek et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer

(2009) M P Hitchins et al.   JOURNAL OF MEDICAL GENETICS